Study2016Industry fundedOpen access

Funded in part by Canola Council of Canada

Interactions between Obesity Status and Dietary Intake of Monounsaturated and Polyunsaturated Oils on Human Gut Microbiome Profiles in the Canola Oil Multicenter Intervention Trial (COMIT)

Pu S, Khazanehei H, Jones PJ, Khafipour E

Frontiers in microbiology · 71 citations

Review labels

Controlled feedingIndustry fundedMechanisms only

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (classified by our AI screen)
Studied in
People
Main outcome
Mechanisms only
Intake measured by
Food provided by researchers

Who paid for it

Funding
Industry funded
Industry group
Canola Council of Canada

Based on 1 listed funder(s) and full-text disclosure statement.

Publication

Published
2016-10-10 · Front Microbiol · vol. 7 · p. 1612
Publisher
Frontiers Media
Cited
93 citations · more than 93% of similar papers · 3.4× the field average
Impact
Top 10% most cited in its field
References
42 works
Access
Open access (journal) · CC-BY
Research areas
Gut microbiota and health · Diet and metabolism studies · Nutritional Studies and Diet
Keywords
Canola, Polyunsaturated fatty acid, Biology, Food science, Gut flora, Obesity, Microbiome, Biotechnology, Fatty acid, Biochemistry, Endocrinology, Bioinformatics

4 authors

From CA

  • Shuaihua PuUniversity of Manitoba
  • H. KhazaneheiUniversity of Manitoba
  • Peter J.H. Jones · correspondingUniversity of Manitoba
  • Ehsan Khafipour · correspondingUniversity of Manitoba

Abstract

Long-term dietary fatty acid intake is believed to induce changes in the human gut microbiome which might be associated with human health or obesity status; however, considerable debate remains regarding the most favorable ratios of fatty acids to optimize these processes. The objective of this sub-study of a double-blinded randomized crossover clinical study, the canola oil multi-center intervention trial, was to investigate effects of five different novel oil blends fed for 30 days each on the intestinal microbiota in 25 volunteers with risk of metabolic syndrome. The 60 g treatments included three MUFA-rich diets: (1) conventional canola oil (Canola); (2) DHA-enriched high oleic canola oil (CanolaDHA); (3) high oleic canola oil (CanolaOleic); and two PUFA-rich diets: (4) a blend of corn/safflower oil (25:75) (CornSaff); and (5) a blend of flax/safflower oil (60:40) (FlaxSaff). Stool samples were collected at the end of each period. DNA was extracted and amplified for 16S rRNA gene pyrosequencing. A total of 17 phyla and 187 genera were identified. While five novel oil treatments failed to alter bacterial phyla composition, obese participants resulted in a higher proportion of Firmicutes to Bacteroidetes than overweight or normal weight groups (P = 0.01). Similarly at the genus level, overall bacterial distribution was highly associated with subjects' body mass index (BMI). Treatment effects were observed between MUFA- and PUFA-rich diets, with the three MUFA diets elevating Parabacteroides, Prevotella, Turicibacter, and Enterobacteriaceae's populations, while the two PUFA-rich diets favored the higher abundance of Isobaculum. High MUFA content feedings also resulted in an increase of Parabacteroides and a decrease of Isobaculum in obese, but not overweight subjects. Data suggest that BMI is a predominant factor in characterization of human gut microbiota profile, and that MUFA-rich and PUFA-rich diets impact the composition of gut microbiota at lower taxonomical levels mainly in obese subjects.

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.